SOURCE: EntreMetrix Corp.

July 13, 2006 09:00 ET

EntreMetrix Announces PreVantix Presents at 14th Annual International Congress on Anti-Aging

IRVINE, CA -- (MARKET WIRE) -- July 13, 2006 -- EntreMetrix, Inc. (OTCBB: ERMX) today announced that its portfolio company PreVantix will be presenting at the 14th Annual International Congress on Anti-Aging Medicine in Chicago June 14th through June 16th. The focal point of PreVantix presentation at the Congress on Anti-Aging will be the Company's first product Prevenox™, a patented, highly effective treatment for Oxidative Stress.

Oxidative Stress has been proven to be a contributing factor to multiple diseases and to accelerate aging. Prevenox™ (L-Ergothioneine USP) is a unique, naturally occurring super antioxidant. It has been shown that Prevenox plays a dual role in both energy regulation and in protecting cells from oxidative damage.

Scott W. Absher, EntreMetrix's CEO, stated, "Anti-aging medicine is the fastest growing segment of medical care in America. The PreVantix team is delivering a product in Prevenox™ that offers physicians in this fast growing segment a new and highly effective tool in their treatment arsenal." Dave Rose, PreVantix CEO, added to Mr. Absher's comments by saying, "We are anxious to meet physicians active in the Anti-Aging practice who will immediately understand the science behind Prevenox™ and the superior antioxidant properties of our product."

PreVantix, an EntreMetrix portfolio company, focuses on the commercialization of patented pharmaceutical science and technologies which address disease management and preventive medicine applications.

EntreMetrix plans to develop a number of portfolio investment scenarios in its quest to increase the Company's net asset value. The Company intends to accelerate its Business Development platform by using its expertise in capital formation, strategic growth and public market entry to the benefit of its eligible portfolio companies. EntreMetrix' expertise provides unique advantages for its eligible portfolio companies, including the possibility of creating a liquid market for the companies' securities. The Company's plan includes equity distribution of each portfolio company to EntreMetrix shareholders of record at the time of a public market entry of the Company's portfolio investments.

About EntreMetrix: Based in Irvine, California, EntreMetrix is a Business Development Company, regulated under the Investment Company Act of 1940, and a provider of essential structural and financial support services to small business clients throughout the United States. The Company's structural support services create value for clients by providing expertise in the areas of employee and financial management -- eliminating the need for clients to manage non-core functions. For many clients, the EntreMetrix relationship results in access to structural and financial resources needed to sharpen business focus and accelerate growth. For more information on EntreMetrix, Inc., visit the company's Web site at or contact Scott W. Absher (888) 798-9100. The Company's corporate offices are located in Southern California at 18101 Von Karman Avenue, Suite 330, Irvine, California 92612.

Safe Harbor Statement: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "ACT"). Statements in this release that relate to the Company's plans and strategies, as well as management's expectations about new and existing products and services, acquisitions and opportunities, market growth, demand for acceptance of new and existing products and services are forward-looking statements. In particular, when used in the preceding discussion, the words "estimated," "believe," "optimistic," "expect," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the ACT and are subject to risks and uncertainties, and actual results could differ materially from those expressed in forward-looking statements. Such risks and uncertainties include, but are not limited to, unfavorable market conditions, increased competition, limited working capital, and failure to implement business strategies, actions by regulatory agencies, and other risks and uncertainties that could cause actual results to differ materially from historical or anticipated results due to many factors. The Company undertakes no obligations to publicly update or revise such statements. For more details, please refer to the Company's Securities and Exchange Commission filings.

Contact Information